Analyst Research Report Snapshot

Title:

Bayer AG

Price:

$175.00

Provider:

MarketLine (a Datamonitor Company)

Date:

08 Apr 2014

Pages:

63

Type:

AcrobatPDF

Companies referenced:

BAYGn.DE

Available for Immediate Download
Summary:

Bayer AG - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360° view of the company. Features: - Detailed information on Bayer AG required for business and competitor intelligence needs - A study of the major internal and external factors affecting Bayer AG in the form of a SWOT analysis - An in-depth view of the business model of Bayer AG including a breakdown and examination of key business segments - Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Bayer AG - Intelligence on Bayer AGnv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Bayer AG, such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Bayer (or ‘the group’) is a Germany-based global chemical and pharmaceutical business group. It operates in Asia Pacific, Europe, North America, Latin America, Africa, and the Middle East. It is headquartered in Leverkusen, Germany, and employed about 110,500 people as on December 31, 2012. The group recorded revenues of E39,760 million ($51,123.4 million*) during the financial year ended December 2012 (FY2012), an increase of 8.8% over FY2011. The operating profit of the group was E3,960 million ($5,091.8 million*) during FY2012, a decrease of 4.6% compared with FY2011. The net profit was E2,446 million ($3,145.1 million*) in FY2012, a decrease of 1% compared with FY2011. *Calculated using a constant conversion rate of E1 = $1.2858 for the financial year ended December 31, 2012. Reasons to Purchase: - Gain understanding of Bayer AG and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Bayer AG as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Bayer AG’s business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.